✦ LIBER ✦

Treatment of metastatic urothelial cancer: opportunities for drug discovery and development

✍ Scribed by Guru Sonpavde; Cora N. Sternberg

Book ID: 109054320
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 115 KB
Volume: 102
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2008.07982.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New drugs and new approaches for the tre

New drugs and new approaches for the treatment of metastatic urothelial cancer

✍ Fabio Calabrò; Cora N. Sternberg 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 111 KB

Opportunities in Drug Discovery for Trea

Opportunities in Drug Discovery for Treatment of AIDS

✍ Arthur D. Broom 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 136 KB

Development and clinical application of

Development and clinical application of drug delivery systems for cancer treatment

✍ T. Takahashi 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 246 KB

Targeting EGFR and HER-2 Receptor Tyrosi

Targeting EGFR and HER-2 Receptor Tyrosine Kinases for Cancer Drug Discovery and Development

✍ Shantaram Kamath; John K. Buolamwini 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 8 KB

Targeting EGFR and HER-2 receptor tyrosi

Targeting EGFR and HER-2 receptor tyrosine kinases for cancer drug discovery and development

✍ Shantaram Kamath; John K. Buolamwini 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB

Conventional anticancer therapy using cytotoxic drugs lacks selectivity and is prone to toxicity and drug resistance. Anticancer therapies targeting aberrant growth factor receptor signaling are gaining interest. The erbB receptor family belongs to the type I, the receptor tyrosine kinases class, an

Encapsulation of Nucleic Acids and Oppor

Encapsulation of Nucleic Acids and Opportunities for Cancer Treatment

✍ Lisa Brannon-Peppas; Bilal Ghosn; Krishnendu Roy; Kenneth Cornetta 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 275 KB